PolyPeptide Group AG provided earnings guidance for the full year 2022. For the period, the company targets revenue growth of 12-14% versus 2021. The Group will continue to invest in modernizing and expanding its infrastructure with capital expenditures as % of 2022 revenue expected to be above 25%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.45 CHF | +1.55% |
|
-7.54% | +68.09% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+68.09% | 1.07B | |
+55.95% | 811B | |
+43.62% | 640B | |
-6.98% | 353B | |
+19.08% | 333B | |
+9.05% | 302B | |
+16.30% | 246B | |
+2.41% | 225B | |
+12.47% | 218B | |
+8.91% | 168B |
- Stock Market
- Equities
- PPGN Stock
- News PolyPeptide Group AG
- PolyPeptide Group AG Provides Earnings Guidance for the Full Year 2022